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During herpes simplex virus infection, expression of the viral DNA polymerase (pol) gene is regulated
temporally as an early (p) gene and is additionally down-regulated at late times at the level of translation
(D. R. Yager, A. I. Marcy, and D. M. Coen, J. Virol. 64:2217-2225, 1990). To examine the role of viral DNA
synthesis in pol regulation, we studied pol expression during infections in which viral DNA synthesis was
blocked, either by using drugs that inhibit Pol or ribonucleotide reductase or by using viral mutants with
lesions in either the pol or a primase-helicase subunit gene. Under any of these conditions, the level of
cytoplasmic pol mRNA was reduced. This reduction was first seen at approximately the time DNA synthesis
begins and, when normalized to levels of other early mRNAs, became as great as 20-fold late in infection. The
reduction was also observed in the absence ofthe adjacent origin of replication, OriL. Thus, althoughpolmRNA
accumulated as expected for an early gene in terms of temporal regulation, it behaved more like that of a late
('y) gene in its response to DNA synthesis inhibition. Surprisingly, despite the marked decrease in pol mRNA
in the absence of DNA synthesis, the accumulation of Pol polypeptide was unaffected. This was accompanied
by loss of the normal down-regulation of translation ofpol mRNA at late times. We suggest a model to explain
these findings.
Herpes simplex virus (HSV) is a large DNA virus that uses
cellular transcriptional and translational machinery for the
expression of its genes. HSV gene expression is regulated as
an ordered cascade (10, 19, 22). The first genes expressed are
the a (immediate-early) genes, which encode regulatory
proteins required for the efficient expression of later genes.
Next, the I (early) genes, which largely encode DNA
replication proteins, are expressed. The levels of early
mRNAs and the rates of early protein synthesis peak at
about 4 to 7 h postinfection and then decline. Early gene
expression is relatively insensitive to inhibition ofviral DNA
synthesis. In contrast, the expression of -y (late) genes,
which largely encode virion proteins, continues to increase
until very late in infection and is relatively sensitive to
inhibition of viral DNA synthesis. The mechanisms that
differentiate the expression of these genes, particularly the
early and late genes, are still poorly understood.
The HSV DNA polymerase (Pol) is required for viral
replication and serves both as a target for antiviral drugs and
as a model eukaryotic DNA polymerase. Previous studies of
its regulation have classified it as an early gene (9, 15, 23,
26-28). pol transcription and mRNA accumulation are abol-
ished by the protein synthesis inhibitor cycloheximide, indi-
cating a requirement for the expression of immediate-early
proteins (23). The time courses ofpol transcription rates and
mRNA accumulation resemble those of other early genes
involved in nucleotide metabolism and viral replication, such
as the thymidine kinase gene (tk) and the major DNA-
binding protein gene (ICP8), although pol expression peaks
somewhat later before declining (15, 23, 26-28). Both pol
transcription and mRNA accumulation, like those of the tk
and ICP8 genes, have been reported to be relatively insen-
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sitive to inhibitors of viral DNA synthesis, at least up to 6.5
h postinfection (9, 23).
However, the kinetics of Pol protein synthesis differ
considerably from those of TK. Whereas the time course of
the rate of TK protein synthesis parallels the time course of
tk mRNA abundance, Pol protein synthesis peaks beforepol
mRNA abundance and then shuts offwhenpol mRNA levels
are still high (27). This is due to inefficient translation ofpol
mRNA at late times in the viral infection (26, 27).
To explore the regulation ofpol gene expression further,
we asked whether the shutoff of Pol protein synthesis at the
level of translation requires viral DNA synthesis. This could
be due, for example, to a requirement for a late gene product
whose synthesis would depend on viral DNA synthesis.
However, in the course of these studies, we unexpectedly
found that pol mRNA accumulation depends on viral DNA
synthesis. After normalizing for levels ofpol mRNA, we did
find that DNA replication is required for translational regu-
lation ofpol expression. We suggest a model to explain these
observations.
MATERIALS AND METHODS
CeUs and viruses. African green monkey kidney (Vero)
cells were grown in Dulbecco's modified Eagle's medium
supplemented with calf serum. Viruses used were HSV type
1 strain KOS and the following mutants derived from it: the
phosphonoacetic acid (PAA)-resistant derivative PKG7 (11);
pol deletion mutant viruses AS1 and AX14 (13); a lacZ
insertion mutant containing a mutation in the gene encoding
the UL5 subunit of the viral primase-helicase, hr99 (29),
generously supplied by Sandra Weller (University of Con-
necticut Health Center, Farmington); and the oriL deletion
mutant ts+7 (17), kindly provided by Priscilla Schaffer
(Dana-Farber Cancer Institute, Boston, Mass.).
Viral DNA synthesis inhibitors. Aphidicolin, the gift of M.
Suffness (National Cancer Institute, Bethesda, Md.), was
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prepared as described previously (3). Hydroxyurea was
obtained from Sigma Chemical Co. (St. Louis, Mo.) and
dissolved in water. Ganciclovir was kindly supplied by D.
Barry (Burroughs Wellcome, Research Triangle Park, N.C.)
and was prepared as previously described for acyclovir (4).
PAA was generously provided by S. Schmidt (Abbott Lab-
oratories, North Chicago, Ill.) and prepared as previously
described (4).
RNA isolation. Vero cells were mock infected or infected
with a multiplicity of 5 PFU per cell. For those infections
carried out in the presence of drugs, aphidicolin (10 ,ug/ml),
hydroxyurea (10 mM), and ganciclovir, (200 ,uM) were added
1 h postinfection while PAA was added simultaneously with
the virus to a final concentration of 0.4 mg/ml. At the
indicated times postinfection, cells were washed twice with
cold phosphate-buffered saline. After addition of 0.5 to 1 ml
of lysis buffer (140 mM NaCl, 1.5 mM MgCl2, 10 mM
Tris-HCl [pH 8.6], 0.5% Nonidet P-40), the cells were
scraped into 1.5-ml tubes and the nuclei were pelleted by
spinning briefly in a microcentrifuge (30 to 60 s). The
supernatant was removed to a new tube. Sodium dodecyl
sulfate (SDS) was added to a final concentration of 0.6%, and
10 to 20 p,g of proteinase K was added. After incubation at
55°C for 1 h, the solution was phenol-chloroform extracted.
The aqueous phase was rendered 1 M ammonium acetate,
and then an equal volume of isopropanol was added. To
determine RNA concentration, a portion of the isopropanol
suspension was pelleted by centrifugation and resuspended
in water, and the A260 was determined spectrophotometri-
cally.
Primer extension analysis. Ten micrograms of pelleted
RNA was resuspended in 30 ,ul of hybridization mix [80%
formamide, 40 mM piperazine-N,N'-bis(ethanesulfonic acid)
(PIPES; pH 6.7), 0.4 M NaCl, 1 mM EDTA]. Gel-purified, 5'
32P-end-labeled primers were added in the following quanti-
ties determined empirically to yield products proportional to
the amount of RNA added: 50 fmol ofpol primer, comple-
mentary to residues 52 to 69 of the majorpolmRNA (26); 100
fmol of tk primer, complementary to residues 68 to 90 of tk
mRNA (11); and 200 fmol of ICP8 primer, corresponding to
residues 72 to 92 of ICP8 mRNA (20). The hybridization
reaction mixtures were placed at 55°C for 2 h and then
precipitated by addition of 70 ,ul of water, 25 p,l of 5 M
ammonium acetate, and 375 p,l of ethanol. Twenty microli-
ters of reverse transcription mix (50 mM Tris [pH 7.6], 60
mM KCl, 10 mM MgCl2, 1 mM each deoxynucleoside
triphosphate [dNTP], 1 mM dithiothreitol, 1 U of RNasin per
p1, 50 p,g of actinomycin D per ml, 0.75 U of avian myelo-
blastosis virus reverse transcriptase) was added to the pre-
cipitated nucleic acids, and the reaction mixture was incu-
bated at 42°C for 1 to 2 h. Reactions were terminated by
phenol-chloroform extraction and ethanol precipitation. Pre-
cipitated nucleic acids were resuspended and separated by
electrophoresis on 10% denaturing polyacrylamide gels.
Radioactive species were visualized by autoradiography,
using preflashed Kodak XAR-5 film. The amounts of primer
extension products were quantified by using either a Betagen
,-scope, a Molecular Dynamics PhosphorImager, or a Mi-
crotek scanner. In the case ofpol primer extension products,
we measured only the closely spaced major products, not the
minor (<10%) species (2, 26). The ratios of pol mRNA
primer extension products to the tk or ICP8 mRNA primer
extension products from untreated KOS-infected cells ver-
sus drug-treated or mutant virus-infected cells were calcu-
lated. The fold reduction in pol mRNA relative to other
mRNAs was then calculated by dividing the politk or poll
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FIG. 1. Primer extension analysis ofpol and tk mRNA levels in
drug-treated infections. Cells were mock infected or infected with
KOS and treated with particular drugs or left untreated, as indicated
above each lane. RNA was harvested at 4 h postinfection and
analyzed in primer extension reactions in which both pol and tk
primers were included. Positions of the tk andpol primer extension
products are noted at the right. This figure was generated by using
the programs Adobe Photoshop and Canvas on a Macintosh com-
puter following scanning of an autoradiogram with a Microtek
scanner.
ICP8 ratio from the untreated wild-type-infected cells by the
same ratio from the drug-treated or mutant-infected cells.
Protein analysis. Immunoblots were performed as previ-
ously described (27) except that 125I-labeled goat anti-rabbit
immunoglobulin G serum (NEN-Dupont, Billerica, Mass.)
was used as the secondary antibody. Bound antibody was
then detected by autoradiography and quantified by using a
Microtek scanner. Quantitative sequential immunoprecipita-
tion reactions were carried out essentially as previously
described (27) except that reaction buffers contained 100 mM
KCl, 5 mM MgCl2, and 50 mM Tris-Cl (pH 7.6) supple-
mented with 0.1% Nonidet P-40 for the antibody binding
steps and 0.1% SDS, 1% Triton X-100, and 1% sodium
deoxycholate for the wash steps. The proteins were sepa-
rated by SDS-polyacrylamide gel electrophoresis and quan-
tified by using a Microtek scanner. The values obtained were
corrected to normalize for differences in methionine content.
The ratio of protein product per mRNA was then calculated
for both tk and pol.
RESULTS
Effects of viral DNA synthesis inhibitors on pol mRNA. In
an initial experiment to examine the role of viral DNA
replication in pol gene expression, Vero cells were infected
with wild-type HSV-1 strain KOS, in the presence or ab-
sence of various DNA synthesis inhibitors that have differ-
ent mechanisms of action. Aphidicolin, though not a sub-
strate analog, inhibits HSV Pol competitively with dNTPs
(5, 8, 16); ganciclovir, after conversion to its triphosphate,
inhibits HSV Pol competitively with dGTP and is a pseudo-
chain terminator (7, 18); PAA is a PPi analog that is thought
to block the PPi release site of HSV Pol, thereby inhibiting
noncompetitively with dNTPs (6, 12). Hydroxyurea, in
contrast, inhibits both cellular and viral ribonucleotide re-
ductase, thereby depleting dNTP pools (14). This variety of
inhibitors was used to ensure that effects would be due to a
block in viral DNA synthesis rather than to drug-specific
side effects. Hydroxyurea was also used to distinguish
between inhibition of viral DNA synthesis generally and
direct inhibition of HSV Pol.
Figure 1 demonstrates the effects of aphidicolin, ganciclo-
vir, and hydroxyurea on the accumulation of two mRNAs,
J. VIROL.
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pol and tk, at 4 h postinfection. While tk mRNA was only
slightly diminished in the presence of the drugs, pol mRNA
was more substantially reduced in the presence of all three
inhibitors. When quantified and normalized to tk mRNA
levels, the reduction in pol mRNA was two- to fourfold,
depending on the drug. To ensure that this reduction re-
flected a decrease inpol mRNA levels and not an increase in
tk mRNA levels, ICP8 mRNA, another early gene product,
was also measured. This analysis revealed nearly identical
results (24). Therefore, inhibition of viral DNA synthesis
either by direct inhibition of Pol or by depletion of dNTP
pools led to a reduction in pol mRNA relative to two early
mRNAs.
Time course of effects of PAA. A more detailed analysis
was performed with the Pol inhibitor PAA by examiningpol,
tk, and ICP8 mRNAs at various times postinfection by
primer extension analysis (Fig. 2A). The amounts of primer
extension products were quantified and were plotted for
each mRNA relative to the maximal amount expressed (this
being 4.5 h postinfection in the absence of drug) (Fig. 2B).
PAA appeared to slightly reduce (-20%) the amount of tk
and ICP8 mRNA at 3 and 4.5 h postinfection compared with
the no-drug controls, but by 9 and 10.5 h there was substan-
tially more tk and ICP8 mRNA in PAA-treated cells than in
untreated cells. In contrast, although PAA had little effect on
pol mRNA at 1.5 h (24) or 3 h (Fig. 2), at 4.5 h, which
corresponds to the onset of viral DNA synthesis, it reduced
this species two- to threefold compared with the no-drug
control. This was similar to the results with the other
inhibitors at 4 h (Fig. 1).
Relative to tk mRNA, pol mRNA was reduced twofold in
the presence of PAA at 4.5 h postinfection. At later times,
however, the reduction relative to tk mRNA became severe.
For example, at 9 h in the absence of PAA, there was a
greaterpol signal than tk signal, but in the presence of PAA,
there was a much greater tk signal than pol signal (Fig. 2).
This corresponds to a 20-fold reduction in the ratio of pol
mRNA to tk mRNA. A similar pattern was observed when
pol mRNA was compared with ICP8 mRNA (Fig. 2), with a
-10-fold reduction at 9 h.
These effects were specific to inhibition of HSV DNA
synthesis because the pol, tk, and ICP8 mRNA profiles of a
PAA-resistant mutant, PKG7, were similar in the presence
or absence of the drug (24). Moreover, a similar time course
experiment carried out with hydroxyurea gave results simi-
lar to those for PAA in KOS-infected cells (24), demonstrat-
ing that the relative decrease in pol mRNA levels during
infection was common to both DNA synthesis inhibitors.
Replication-negative mutants exhibit decreases in pol
mRNA. To examine the role of DNA replication in pol
expression further, we studied replication-negative mutants
of HSV, thereby avoiding the use of drugs. The first mutants
examined were mutants AS1 and AX14, which contain
deletions in pol gene protein-coding sequences. These mu-
tants do not replicate in Vero cells and produce truncated
Pol proteins (13). Figure 3 compares the expression of pol
and tk mRNAs by these two mutants with that of KOS in the
absence or presence of PAA. The time point used in this
experiment was 8 h postinfection, at which time the effect of
PAA on thepol/tk mRNA ratio is fairly severe (Fig. 2 and 3).
The pol deletion mutants expressed a polltk mRNA ratio
similar to that produced by the wild-type virus in the
presence of PAA, with polltk mRNA ratios <10% of that of
KOS in the absence of drug.
We then examined a third replication-negative mutant
virus, hr99. This mutant contains a lesion in the ULS gene,
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FIG. 2. Effect ofPAA onpol mRNA levels. (A) Primer extension
analysis. Cytoplasmic RNA was harvested from cells infected by
KOS in either the presence (-) or absence (E) of PAA (0.4 mg/ml)
at the time (in hours) noted above each lane. Primer extensions were
carried out with pol, tk, and ICP8 primers. Positions of the specific
primer extension products are noted at the right. The figure was
generated as described in the legend to Fig. 1. (B) The amount of
radioactivity in the primer extension gel was quantified for each
extension product and normalized to the amount at 4.5 h postinfec-
tion (p.i.) in the absence of drug, which was given a value of 1.0.
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FIG. 3. pol mRNA expression by pol mutants. Cells were in-
fected with KOS in the presence or absence of PAA or with AS1 or
AX14 in the absence of drug, as indicated above each lane. RNA
was harvested 8 h postinfection and analyzed by primer extension
using tk and pol primers. Positions of specific primer extension
products are shown at the right. The image was generated as
described in the legend to Fig. 1.
which encodes a subunit of the HSV primase-helicase (29).
At 9 h postinfection, this mutant also exhibited a polltk
mRNA ratio similar to that of KOS in the presence of PAA
(Fig. 4). Thus, bothpol and ULS mutants that are replication
negative exhibited decreases in pol mRNA accumulation.
The decrease in pol mRNA does not depend on OrL. One
mechanism that we could envision to account for our find-
ings was based on the close proximity (55 bp) of the start site
ofpol transcription to one of the HSV origins of replication,
OlL (26). We hypothesized that use of this origin might
stimulate transcription of the pol gene, as suggested by
Tomalski et al. (21). According to this hypothesis, when
DNA synthesis was inhibited, the decrease in pol mRNA
levels would be due to lack of transcriptional stimulation by
activation of o0L. To examine this possibility, we analyzed
pol mRNA levels during infection with the oiL deletion
mutant ts+7, which is still replication competent, presum-
ably as a result of use of its two copies of the other HSV
origin, ons (17). If use of the adjacent o0L were required to
stimulate pol transcription, then relative pol mRNA levels
should be lower in ts+7-infected cells than in KOS-infected
cells, especially at late times, and the same in ts+7-infected
cells in the presence or absence of PAA.
Figure 5 shows the pol, tk, and ICP8 mRNA levels at
various times following infection by ts+7 in the presence and
absence of PAA. Comparison of Fig. 5 with Fig. 2A shows
that in the absence of PAA, the relative levels ofpol mRNA
in ts+7-infected cells were similar to those in KOS-infected
cells throughout the time course. This result was confirmed
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FIG. 4. pol mRNA expression by mutant hr99. Cells were in-
fected with KOS in the presence or absence of PAA or with hr99 in
the absence of drug, as indicated above each lane. RNA was
harvested 9 h postinfection and analyzed by primer extension using
tk, pol, and ICP8 primers. Positions of specific primer extension
products are shown on the right. The image was generated as
described in the legend to Fig. 1.
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FIG. 5. pol mRNA expression by ts+7. The experiment was
conducted identically to that in Fig. 2A except that the virus used
was ts+7.
by direct comparisons of mRNAs from KOS-infected cells
and ts+7-infected cells (24). As was true for wild-type strain
KOS (Fig. 2), a severe decrease inpol mRNA levels relative
to those for tk and ICP8 was seen in the presence of PAA
despite the absence of a functional oniL. Again, the ratio of
polmRNA to tk or ICP8 mRNA decreased by 20- or 10-fold,
respectively, in the presence of PAA. Therefore, the use of
the adjacent OniL had no apparent effect on relative pol
mRNA levels.
Interestingly, although the deletion in ts+7 removes se-
quences from the putative pol and ICP8 promoters (20, 26),
the overall level ofpol and ICP8 mRNAs, normalized to the
tk level, were not noticeably decreased relative to KOS.
However, the deletion (17) removes parts of two Spl con-
sensus sequences ca. 70 bp from each start site and replaces
them with a single very similar sequence. Thus, it may be
that in ts+7, the same Spl binding site serves to activate
transcription of both the ICP8 and pol genes.
Effects of inhibition of DNA synthesis on Pol protein syn-
thesis. Having established the effects of inhibiting viral DNA
synthesis on pol mRNA accumulation, we then sought to
determine the effect on Pol protein synthesis. We first
examined the amount of Pol and TK protein that accumu-
lated during infections by KOS, KOS in the presence of
PAA, and the hr99 primase-helicase mutant. Infected cell
protein samples were prepared at 18 h postinfection and
fractionated by SDS-polyacrylamide gel electrophoresis,
and TK and Pol were visualized by Western blotting (immu-
noblotting). To obtain a more quantitative assay, three
different amounts of each protein sample were analyzed; the
intensity of the autoradiographic signal reflected the amount
of protein loaded on the gel (Fig. 6). When Pol protein levels
were normalized to TK protein levels, very little difference
was seen in the amount of Pol protein produced under the
different conditions. For example, there was no apparent
difference in the relative amounts of Pol protein harvested
from hr99- and KOS-infected cells and only a slight decrease
harvested from cells infected with KOS in the presence of
PAA. These differences were far less substantial than the
difference inpol mRNA levels in the presence or absence of
PAA (compare the areas under the curves in Fig. 2B forpol
and tk mRNAs).
One possible explanation for this result was that viral
DNA synthesis is required for the normal shutoff of transla-
tion ofpol mRNA (26, 27) as well as for accumulation ofpol
mRNA. To determine whether this was the case, cells were
pulse-labeled with [35S]methionine for 2 h starting at 4 h or 7
4
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FIG. 6. Similar accumulation of Pol and TK in the presence or
absence of DNA synthesis. Cells were infected with KOS in the
presence or absence of PAA or with hr99 in the absence of drug, as
indicated above each lane. At 18 h postinfection, cells were har-
vested and 1, 3, or 10 pAl of each extract (indicated by the wedges)
was electrophoresed on an SDS-polyacrylamide gel. The proteins in
the gel were transferred to nitrocellulose and probed with anti-Pol
and anti-TK antisera. The image was generated as described in the
legend to Fig. 1.
h postinfection with KOS in the presence or absence of PAA
to permit measurements of rates of Pol and TK protein
synthesis at these times. At the end of the radioactive pulse,
lysates were prepared from infected cells and reacted with
anti-Pol or anti-TK antisera under conditions that immuno-
precipitated these proteins quantitatively. In parallel, RNA
was isolated and the amounts of pol and tk mRNAs were
measured by primer extension. The expected decrease inpol
mRNA relative to tk mRNA was observed when replication
was inhibited. For example, as shown in Fig. 7A, at 9 h in
KOS-infected cells in the absence of drug, there were similar
pol and tk primer extension signals, whereas in the presence
KOS +KIAA
A
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B
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FIG. 7. Increased efficiency of pol mRNA translation in PAA.
Cells were infected with KOS in the presence or absence of PAA, as
indicated above each lane. At 7 h postinfection, the cells were
pulsed with [35S]methionine; 2 h later, the cells were harvested and
analyzed for RNA by primer extension as described for Fig. 1 (A) or
for Pol and TK protein synthesis (B) by immunoprecipitation and
SDS-polyacrylamide gel electrophoresis. The multiple TK polypep-
tides are likely due to mild proteolysis as observed previously (11).
The image was generated as described in the legend to Fig. 1.
TABLE 1. Changes in translational efficiency of KOS pol mRNA
(Pol synthesis/pol
Treatment mRNA)/(TK synthe- Change duringTreatment sis/tk mRNA)a infection'
Early Late
No drug 0.34 0.072 4.7-fold decrease
PAA 0.44 0.57 1.3-fold increase
a Cells were infected with KOS in the presence or absence of PAA (0.4
mg/ml). At 4 h (early) or 7 h (late) postinfection, cells were pulse-labeled with[3 S]methionine; 2 h later, they were harvested and assayed for Pol and TK
protein synthesis and forpol and tk mRNAs. Protein synthesis was quantified
by densitometry of autoradiograms of SDS-polyacrylamide gels of immuno-
precipitated proteins, and mRNAs were quantified by analysis of primer
extension products. The values obtained were used to calculate the ratios in
arbitrary units.
b The change in ratio of Pol protein synthesis perpol mRNA to TK protein
synthesis per tk mRNA from early to late in infection.
of PAA, thepol signal was much weaker than the tk signal (a
>12-fold decrease in the politk mRNA ratio).
Remarkably, the ratio of Pol to TK protein synthesis was
similar in the presence or absence of PAA late in infection
(Fig. 7B), even though there was much lesspolmRNA in the
presence of PAA (Fig. 7A). During KOS infection in the
absence of PAA, the translational efficiency of pol mRNA
(amount of protein synthesized per mRNA molecule) de-
creased substantially between early and late times postinfec-
tion (Table 1), consistent with previous results (27). In
contrast, during KOS infection in the presence of PAA,
there was no decrease in translational efficiency of pol
mRNA (Table 1). Similar results were obtained by compar-
ing pol deletion mutant AS1 with KOS (25). These results
confirmed our hypothesis that when DNA synthesis is inhib-
ited, the shutoff of pol mRNA translation is relieved. This
would account for the normal levels of Pol protein observed
(Fig. 6) despite the severe decrease in pol mRNA.
DISCUSSION
In this study, we found that when HSV DNA synthesis
was inhibited by using a variety of drugs or mutants, pol
mRNA accumulation decreased dramatically relative to
other early mRNAs. However, this decrease in pol mRNA
did not result in decreased accumulation of Pol protein.
Rather, under conditions in which DNA synthesis was
inhibited, the normal shutoff of translation ofpolmRNA late
in infection was relieved, thereby offsetting the decrease in
mRNA accumulation. We discuss these results in terms of
current understanding of the cascade of HSV gene expres-
sion and in terms of the possible mechanisms and biological
significance of the rather complicated regulatory phenomena
that we have uncovered.
pol mRNA is early temporally but late in dependence on
DNA synthesis. As shown previously (15, 23, 26-28) and
reiterated here, pol is an early (1) gene in terms of its time
course of expression, especially in terms of the decline in
transcription rate (28), mRNA accumulation, and protein
synthesis after 7 h postinfection. The peak of pol mRNA
accumulation comes later than that of ICP8 mRNA, in
agreement with the assignment of these genes to the 12 and
1 groups, respectively, in one classification (19) and to the
late 13 and early 13 groups, respectively, in another classifi-
cation (28). (However, we disagree with the assignment of tk
mRNA to the 02 group [19], as we find that tk mRNA and
protein synthesis more closely parallels that of ICP8 than
VOL. 67, 1993
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that of pol [Fig. 2 and 5 and reference 24], similar to
transcription rate measurements of Zhang and Wagner [28],
who placed both tk and ICP8 in the early 13 group.)
In contrast, when sensitivity to inhibition of DNA synthe-
sis is considered, pol mRNA accumulation is more akin to
that of a late gene than that of an early gene. In our hands,
the peak expression of early genes such as tk and ICP8 is
decreased somewhat by inhibition of DNA synthesis, not
enhanced as commonly considered, although the expression
of these early genes continues for longer times. However,
pol mRNA accumulation decreased substantially when DNA
synthesis was inhibited relative to that of tk and ICP8. This
finding would appear to conflict with its assignment by
Holland et al. (9) as an early mRNA on the basis of its
relative insensitivity to the DNA synthesis inhibitor arabi-
nosylthymine. This apparent discrepancy may be due to the
isolation of polyribosomal RNA by Holland et al. (9), which
may have underrepresented total cytoplasmic pol RNA in
untreated cells relative to treated cells (26; this report). Our
results are consistent with those of Weinheimer and McK-
night (23), who noted that PAA tended to lower the level of
pol mRNA at 8, 10, and 12 h postinfection without signifi-
cantly altering the patterns of tk and ICP8 mRNA accumu-
lation.
How should pol be classified, then-as an early or a late
gene? Because pol mRNA and Pol polypeptide behave
temporally as early gene products, because Pol polypeptide
synthesis is, in fact, insensitive to inhibition of DNA syn-
thesis, and because most, if not all, other replication proteins
are early gene products, we favor the continued classifica-
tion of pol as an early (1B) gene. Nevertheless, its unusual
behavior emphasizes the variability in behavior among dif-
ferent members of the same kinetic class (19, 22, 28).
Possible mechanisms of pol regulation. One can envision
many different mechanistic models that could account for
our results. One such model is thatpolmRNA accumulation
is sensitive to inhibition of viral DNA synthesis becausepol
transcription is up-regulated upon viral DNA replication.
Arguing against this model are results showing that pol
transcription measured by pulse-labeling decreases at times
when DNA synthesis and late gene transcription remain high
(28) and that the pol transcription rate measured by nuclear
runoff is insensitive to inhibition by PAA (23). Also, one
possible mechanism for transcriptional up-regulation, acti-
vation of ofiL, was ruled out by our studies of the o0L
deletion mutant ts+7. Additionally, this model would not
explain the dependence of translational down-regulation of
pol mRNA on viral DNA synthesis.
Because many of the drugs and mutations that we used to
inhibit DNA synthesis inactivate Pol function, a second
model to explain our results would entail autogenous nega-
tive regulation of pol translation, akin to the situation in
bacteriophage T4, in which T4 DNA polymerase binds to its
own mRNA and negatively regulates its translation (1).
However, given that the primase-helicase mutant hr99 ex-
hibits the same synthesis of Pol polypeptide as do pol
mutants, there is no need to invoke autogenous regulation. It
is still possible to contrive scenarios that would explain the
data via autogenous regulation by Pol; however, we do not
presently favor such a model.
A third model is that a late gene product is responsible
both for stabilizingpol mRNA, thereby increasing its steady-
state levels, and for decreasing net pol mRNA translation
efficiency. Specifically, if a late gene product binds pol
mRNA, it may simultaneously prevent degradation of the
mRNA and inhibit its translation. It could act on a fraction of
pol mRNA, thereby totally sequestering this fraction from
nucleases and ribosomes, or it could act equally on all pol
mRNAs, thereby reducing the probability that they would
encounter nucleases or ribosomes. This model has the
appeal of simplicity since a single event explains both
observed phenomena, the change in pol mRNA levels and
the change in pol mRNA translational efficiency in the
absence of replication.
Does the regulation have adaptive significance? A final
question is, what could be the selective advantage, if any, of
the unusual regulation of pol expression that we have
observed, especially since the net result of inhibition of
DNA synthesis is the same amount of Pol protein? A related
question is why much of the regulation appears to be
posttranscriptional. It may be that Pol accumulates with a
different time course in the presence or absence of DNA
synthesis and that this both makes a difference and is
facilitated by posttranscriptional mechanisms. A second
speculation is that this regulation is not confined to pol
expression but operates for a number of other HSV genes,
such as those encoding other relatively nonabundant repli-
cation proteins, and that the effects on these genes lead to
different amounts of protein synthesized. Further studies to
determine how widespread this regulation is and its mecha-
nisms will likely be necessary to answer questions regarding
its adaptive significance to HSV.
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